Federated Hermes, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 5,659 shares of REGN stock, worth $4.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,659

Previous 3,784 49.55%

Holding current value

$4.28 Million

Previous $3.98 Million 49.56%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.92 Million - $2.25 Million	1,875 Added 49.55%	5,659 $5.95 Million
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $5.64 Million - $6.85 Million	-6,391 Reduced 62.81%	3,784 $3.98 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $6.28 Million - $6.91 Million	6,961 Added 216.58%	10,175 $9.79 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $324,025 - $368,550	418 Added 14.95%	3,214 $2.82 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $110,792 - $135,099	160 Added 6.07%	2,796 $2.3 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $234,510 - $278,167	335 Added 14.56%	2,636 $1.89 Million
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $92,546 - $112,467	-136 Reduced 5.58%	2,301 $1.89 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $1.84 Million - $2 Million	-2,605 Reduced 51.67%	2,437 $1.76 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $212,942 - $268,722	371 Added 7.94%	5,042 $3.47 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $587,282 - $791,297	1,071 Added 29.75%	4,671 $2.76 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $32,731 - $38,413	-55 Reduced 1.5%	3,600 $2.51 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $125,000 - $154,323	230 Added 6.72%	3,655 $2.31 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $138,915 - $164,792	-242 Reduced 6.6%	3,425 $2.07 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $66,664 - $78,754	141 Added 4.0%	3,667 $2.05 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $411,885 - $505,440	-922 Reduced 20.73%	3,526 $1.67 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $273,587 - $347,764	572 Added 14.76%	4,448 $2.15 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $90,973 - $109,921	167 Added 4.5%	3,876 $2.17 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $94.3 Million - $123 Million	-191,254 Reduced 98.1%	3,709 $2.31 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $52.6 Million - $77.4 Million	156,470 Added 406.49%	194,963 $95.2 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $6.92 Million - $9.5 Million	25,232 Added 190.27%	38,493 $14.5 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $508,088 - $591,568	-1,858 Reduced 12.29%	13,261 $3.68 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $5.06 Million - $7.01 Million	-16,889 Reduced 52.76%	15,119 $4.73 Million
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $4.64 Million - $5.48 Million	12,477 Added 63.88%	32,008 $13.1 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $5.79 Million - $6.95 Million	17,234 Added 750.28%	19,531 $7.29 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $77,601 - $90,280	-221 Reduced 8.78%	2,297 $928,000
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $266,954 - $323,600	-938 Reduced 27.14%	2,518 $868,000
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $105,483 - $131,522	334 Added 10.7%	3,456 $1.19 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $70,291 - $92,110	-196 Reduced 5.91%	3,122 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $1.43 Million - $1.67 Million	3,318	3,318 $1.48 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Regeneron Pharmaceuticals, Inc. Transaction History